How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

331 results for

Antepartum Depression

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Use of Antidepressants in Breastfeeding Mothers

Database Syst Rev 2007;(3):CD006309. 40. Brandon AR, Freeman MP. When she says ‘‘no’’ to med- ication: Psychotherapy for antepartum depression. Curr Psychiatry Rep 2011;13:459–466. 41. Cuijpers P, Brannmark JG, van Straten A. Psychological treatment of postpartum depression: A meta-analysis. J Clin Psychol 2008;64:103–118. 42. O’Hara MW, Schlechte JA, Lewis DA, et al. Prospective study of postpartum blues. Biologic and psychosocial fac- tors. Arch Gen Psychiatry 1991;48:801–806. 43. Dekker JJ, Koelen (...) and infants and do not delineate an exclusive course of treatment or serve as standards of medical care. Variations in treatment may be appropriate according to the needs of an individual patient. Background P ostpartum depression (PPD) (sometimes referred to as pregnancy-related mood disorder) is one of the most common and serious postpartum conditions, affecting 10–20% of mothers within the ?rst year of childbirth. 1 Studies have found that up to 50% of women with PPD are undiagnosed. 2 Risk factors

2015 Academy of Breastfeeding Medicine

143. Obesity in pregnancy

associated with obesity in pregnancy Pre-pregnancy BMI is a greater determinant of healthy outcomes for the woman and her newborn than gestational weight gain (GWG). 1 The higher the pre-pregnancy BMI the greater the associated risk. Table 7. Risks of obesity in pregnancy Period Health risk Preconception • Infertility 13 • Pre diabetes (e.g. impaired fasting glucose or impaired glucose tolerance) • Type 2 Diabetes Antenatal • Antepartum stillbirth 14 • Miscarriage 1,15 • Maternal mortality 16 • Diabetes (...) (Gestational diabetes mellitus and Diabetes in Pregnancy ) 14 • Preeclampsia 14 • Obstructive sleep apnoea—may be related to adverse fetal outcomes 14 • Thromboembolic disease 14 • Cholecystitis 14 • Depression 4 • Difficulties with abdominal palpitation and obtaining adequate auscultation of fetal heart and cardiotocograph (CTG) • Suboptimal ultrasonography 5 • Diagnosis of congenital abnormality 17 • Preterm birth (PTB)—mostly associated with comorbidities 14,18 • Increased odds of dizygous twinning 19

2015 Queensland Health

144. Gestational diabetes mellitus

• There is limited evidence or consensus regarding specific antepartum tests or their frequency 54 • Monitoring type and frequency is influenced by the presence of other pregnancy complications (e.g. antepartum haemorrhage, preeclampsia, fetal growth restriction) as well as severity of maternal hyperglycaemia 24 • Fetal abdominal circumference (AC) greater than or equal to 75% for gestational age, measured at 29 to 33 weeks gestation, correlates with an increased risk for birth of an LGA infant 55 Fetal growth (...) for glycaemic management o Addition of pharmacologic therapy 3.3 Psychosocial support Table 14. Psychosocial support Aspect Consideration Context • Emotional well-being is an important part of diabetes care and self- management 8 • Rapport between the woman and the health care provider can enhance compliance 56 • Barriers to effective treatment response in women with GDM include depression, eating disorders, stress and anxiety 57 Information and education • Individualise the approach to management. Take

2015 Queensland Health

145. Antenatal corticosteriods given to women prior to birth to improve fetal, infant, child and adult health

Chapter 14: Use of antenatal corticosteroids for women with specific risk factors for preterm birth 134 14.1 Women with a history of previous preterm birth 138 14.2 Women in preterm labour 151 14.3 Women with preterm prelabour rupture of membranes at risk of preterm birth 164 14.4 Women with chorioamnionitis at risk of preterm birth 180 14.5 Women with antepartum haemorrhage at risk of preterm birth 186 14.6 Women with a multiple pregnancy (twins and higher order) 198 14.7 Women with diabetes mellitus (...) in preterm labour – Repeat course of antenatal corticosteroids 372 Page 3 M17 Women with preterm prelabour rupture of membranes – Single course of antenatal corticosteroids 376 M18 Women with preterm prelabour rupture of membranes – Repeat antenatal corticosteroids .. 380 M19 Women with chorioamnionitis at risk of preterm birth – Single course of antenatal corticosteroids 384 M20 Women with chorioamnionitis at risk of preterm birth – Repeat antenatal corticosteroids 388 M21 Women with antepartum

2015 Clinical Practice Guidelines Portal

146. Umbilical Cord Prolapse

to the woman (possibly with her companions in labour) at a mutually convenient time. After obstetric emergencies, women can be psychologically affected by postnatal depression, post- traumatic stress disorder or fear of further childbirth. Women with cord prolapse and those who undergo urgent transfer to hospital might be particularly vulnerable to emotional problems. 67 5.2 Training All staff involved in maternity care should receive training in the management of obstetric emergencies including (...) (37 weeks or more). Cochrane Database Syst Rev 2006;(1):CD005302. 30. Ezra Y , Strasberg SR, Farine D. Does cord presentation on ultrasound predict cord prolapse? Gynecol Obstet Invest 2003;56:6–9. 31. Kinugasa M, Sato T, Tamura M, Suzuki H, Miyazaki Y , Imanaka M. Antepartum detection of cord presentation by transvaginal ultrasonography for term breech presentation: potential prediction and prevention of cord prolapse. J Obstet Gynaecol Res 2007;33:612–8. 32. Phelan JP , Boucher M, Mueller E

2014 Royal College of Obstetricians and Gynaecologists

147. Diabetes distress is associated with adverse pregnancy outcomes in women with gestational diabetes: a prospective cohort study. Full Text available with Trip Pro

diabetes distress (OR 4.70, p = .02) and parity (OR 0.21, p = .02) but not antepartum depressive symptoms were related to adverse pregnancy outcomes.Diabetes distress is likely in women with GDM and our findings suggest an association between both diabetes distress, parity and adverse pregnancy outcomes in women with GDM. This warrants replication and further research into the underlying mechanisms explaining the impact of diabetes distress in GDM and potential interventions to reduce distress. (...) Diabetes distress is associated with adverse pregnancy outcomes in women with gestational diabetes: a prospective cohort study. Around 12% of pregnant women develop gestational diabetes mellitus (GDM), which is associated with increased health risks for both mother and child and pre- and postpartum depression. Little is known about the relationship of GDM with diabetes-specific emotional distress (diabetes distress). The aims of this study are to assess the prevalence of diabetes distress

2019 BMC Pregnancy and Childbirth

148. Transgender men, pregnancy, and the "new" advanced paternal age: A review of the literature. (Abstract)

to transgender individuals, especially transgender men during pregnancy, as well as research that addresses evidence-based practice remain limited. In this review, we discuss obstetrical issues for transgender men who are ≥35 years old, termed the "new" advanced paternal age. We review preconception care and focus on fertility issues, the impact of stopping gender-affirming hormonal treatment, and age-appropriate health maintenance. We review antepartum and postpartum care, including labor and delivery (...) , monitoring for perinatal depression, contraception, and chest feeding. Finally, we conclude with suggestions for areas for further research and study.Copyright © 2019 Elsevier B.V. All rights reserved.

2019 Maturitas

149. Antidepressant Use During Pregnancy: Considerations for the Newborn Exposed to SSRIs/SNRIs

to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 2008;83(1):68-76. 10 Pedersen LH, Henriksen TB, Vestergaard M, Olsen J, Bech BH. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 2009;339:b3569-b3575. 11 Chung TKH, Lau TK, Yip ASK, Chiu HFK, Lee DTS. Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosom Med (...) attention, such as depression and anxiety, are common during pregnancy. While there are risks to pharmaceutical treatment during pregnancy, untreated or incompletely managed depr ession also carries risks for the exposed newbor n. After car eful consideration of the risks and benefits of pharmaceutical treatment, many women and their caregivers decide to continue treatment with SSRIs/SNRIs during their pregnancy. While most newborns born to women who continue SSRI/SNRI treatment during pregnancy

2013 British Columbia Perinatal Health Program

150. Investigation and Management Small-for-Gestational-Age Fetus

assessment of wellbeing with umbilical artery Doppler unless they develop specific pregnancy complications, for example antepartum haemorrhage or hypertension. However, they should be offered a scan for fetal size and umbilical artery Doppler during the third trimester. Serial ultrasound measurement of fetal size and assessment of wellbeing with umbilical artery Doppler should be offered in cases of fetal echogenic bowel. Abdominal palpation has limited accuracy for the prediction of a SGA neonate (...) need to be assessed on an individual basis. The evidence for an association with asthma, thyroid disease, inflammatory bowel disease and depression is less convincing. Studies report a weak or non–significant association with LBW but do not differentiate between the effect on SGA and preterm birth, and with confidence intervals [CIs] often crossing one. Therefore, if uncomplicated and adequately treated, these are not considered to be risk factors for a SGA fetus. 20,21 Maternal risk factors

2013 Royal College of Obstetricians and Gynaecologists

151. Pre-conception - advice and management

planning a pregnancy; and managing women who are underweight prior to conception. New sections on rheumatological conditions and inflammatory bowel disease have also been added. Creation of a general section on mental health issues that incorporates previous information on depression, bipolar disorder, and psychosis and schizophrenia. Minor changes to the management recommendations on alcohol advice; managing a woman with diabetes planning to conceive; referral of women with asthma for preconception

2017 NICE Clinical Knowledge Summaries

153. Caesarean section

individual CS. [new 2011] [new 2011] 1.4.4 1.4.4 Preoper Preoperativ ative testing and prepar e testing and preparation for CS ation for CS 1.4.4.1 Pregnant women should be offered a haemoglobin assessment before CS to identify those who have anaemia. Although blood loss of more than 1000 ml is infrequent after CS (it occurs in 4–8% of CS) it is a potentially serious complication. [2004] [2004] 1.4.4.2 Pregnant women having CS for antepartum haemorrhage, abruption, uterine rupture and placenta praevia (...) ] 1.7.1.8 Healthcare professionals caring for women who have had a CS should inform women that after a CS they are not at increased risk of difficulties with breastfeeding, depression, post-traumatic stress symptoms, dyspareunia and faecal incontinence. [2004] [2004] 1.7.1.9 While women are in hospital after having a CS, give them the opportunity to discuss with healthcare professionals the reasons for the CS and provide both verbal and printed information about birth options for any future pregnancies

2011 National Institute for Health and Clinical Excellence - Clinical Guidelines

154. Fetal Doppler Indices in Predicting Perinatal Outcome Among Severely Hypertensive Pregnant Patients.

hypertension (gestational hypertension, preeclampsia, chronic hypertension and chronic hypertension with superimposed preeclampsia). Singleton living fetus. Exclusion Criteria: Maternal medical disorders rather than hypertension. Fetal congenital anomalies. Rupture of membrane. Antepartum hemorrhage (placenta previa or accidental hemorrhage). The maternal administration of respiratory depressants within 2 hours from the delivery of the fetus (e. g., opioid analgesic ) Contacts and Locations Go

2018 Clinical Trials

155. Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa

: Not yet recruiting First Posted : May 31, 2018 Last Update Posted : May 31, 2018 See Sponsor: Assiut University Information provided by (Responsible Party): ramy nasser, Assiut University Study Details Study Description Go to Brief Summary: Antepartum hemorrhage is defined as bleeding from or within the female genital tract, occurring from 28+0 weeks of pregnancy and till delivery of the fetus. it occurs in 3-5% of pregnancies and is an important cause of perinatal and maternal morbidity and mortality (...) : No Additional relevant MeSH terms: Layout table for MeSH terms Obstetric Labor, Premature Placenta Previa Obstetric Labor Complications Pregnancy Complications Placenta Diseases Magnesium Sulfate Nifedipine Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs Anesthetics Central Nervous System Depressants Anti-Arrhythmia Agents Anticonvulsants Calcium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Calcium-Regulating

2018 Clinical Trials

156. Prevalence and risk factors of gestational diabetes mellitus: findings from a universal screening feasibility program in Lima, Peru. Full Text available with Trip Pro

and was associated with maternal obesity, family history of diabetes and antepartum depression among Peruvian women. Intervention programs aimed at early diagnoses and management of GDM need to take maternal obesity, family history of diabetes and antepartum depression into account. (...) was conducted among 1300 pregnant women attending a prenatal clinic in Lima, Peru. GDM was diagnosed using an Oral Glucose Tolerance Test (OGTT) performed between 24 and 28 gestational weeks using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. Depression status was assessed using the Patient Health Questionnaire-9. Multivariate logistic regression models were used to identify risk factors of GDM.Approximately 16% of pregnant women were diagnosed with GDM

2018 BMC Pregnancy and Childbirth

157. Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology

to Primary Outcome Measures : Compliance antepartum [ Time Frame: From entry into the study until delivery (through study completion, an average of 9 months which is duration of the pregnancy) ] To compare compliance with buprenorphine versus buprenorphine/naloxone medication-assisted treatment (MAT) in pregnant women. Compliance will include the incidence of urine toxicology testing positive for illicit substances during prenatal care and at the time of admission for delivery. Compliance postpartum (...) [ Time Frame: 2 month period postpartum ] To compare compliance with buprenorphine versus buprenorphine/naloxone medication-assisted treatment (MAT) in the postpartum period. Compliance will include the incidence of urine toxicology testing positive for illicit substances from the time of discharge from the hospital following the delivery over a 2 month period postpartum (postpartum period). Dosing antepartum [ Time Frame: From entry into the study until delivery (through study completion, an average

2018 Clinical Trials

158. HIV Exposure and Formula Feeding Predict Under-2 Mortality in HIV-Uninfected Children, Botswana. Full Text available with Trip Pro

zidovudine, and 1% took <2 weeks of any antiretrovirals antepartum. Twenty four-month vital status was available for 888 (99.4%) children. HIV-exposed uninfected children had a significantly higher risk of death compared with children of HIV-uninfected mothers (5.0% vs 1.8%) (adjusted hazard ratio 3.27, 95% CI 1.44-7.40). High collinearity between maternal HIV status and child feeding method precluded analysis of these factors as independent predictors of mortality. Preterm birth, low birth weight (...) , and congenital anomaly were also associated with mortality (in separate analyses), but maternal socioeconomic factors, depression, substance use, and social support were not significant predictors.The strongest predictors of 24-month mortality among children in Botswana were HIV exposure and formula feeding, although the relative contribution of these factors to child health could not be separated.Copyright © 2018 Elsevier Inc. All rights reserved.

2018 Journal of Pediatrics

159. Evaluation of Copeptin Levels in Elective Cesarean Section With Different Anesthetic Technique

Inclusion Criteria: 18-40 years of age ASA I-II 36-40 gestational weeks BMI ≤ 40 Undergoing elective cesarean section Exclusion Criteria: Coagulopathy Known central or peripheral nerve disease fetal anomalies birth weight less than 2000 grams and above 4500 grams, infants with a risk of meconium or amniotic fluid aspiration kidney failure, diabetes mellitus, hypertension, cardiac disease, antepartum hemorrhage, asthma bronchiole, Rh incompatibility, congenital malformations Contacts and Locations Go (...) Device Product: No Keywords provided by Ece YAMAK ALTINPULLUK, Istanbul University: copeptin levels Cesarean section general anesthesia spinal anesthesia Additional relevant MeSH terms: Layout table for MeSH terms Diabetes Insipidus Fetal Distress Kidney Diseases Urologic Diseases Pituitary Diseases Endocrine System Diseases Signs and Symptoms Anesthetics Arginine Vasopressin Central Nervous System Depressants Physiological Effects of Drugs Hemostatics Coagulants Vasoconstrictor Agents Antidiuretic

2018 Clinical Trials

160. Tranexamic Acid in Pregnancies With Vaginal Bleeding

Description Go to Brief Summary: Tranexamic acid has been proposed and used for prevention and management of antepartum and postpartum hemorrhage. Condition or disease Intervention/treatment Phase Vaginal Bleeding During Pregnancy Drug: Tranexamic Acid Not Applicable Detailed Description: Bleeding during pregnancy is associated with a three- to fourfold increase in perinatal mortality. Hemorrhage in pregnancy is characterized by activation of the fibrinolytic system. Tranexamic acid is a potent (...) Model: Single Group Assignment Intervention Model Description: Tranexamic acid was prescribed for women with abnormal vaginal bleeding in the first trimester less than 20 weeks gestation (threatened and recurrent miscarriage) and Antepartum hemorrhage (abruption , placenta previa, and unknown causes for vaginal bleeding) Masking: None (Open Label) Primary Purpose: Treatment Official Title: Tranexamic Acid in Pregnancies With Early and Late Onset Vaginal Bleeding:One Arm Clinical Trial Actual Study

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>